desferal injection 2 g
yousif mahmood hussain & bahrain pharmacy co - desferrioxamine methane sulphn - injection - 2
prochlorperazine injection bp 12.5mg/ml. 12.5 mg/ml solution for injection
mercury pharmaceuticals (ireland) ltd - prochlorperazine mesilate - solution for injection - 12.5 mg/ml
prochlorperazine injection bp 25mg in 2ml 25 mg/ml solution for injection
mercury pharmaceuticals (ireland) ltd - prochlorperazine mesilate - solution for injection - 25 mg/ml
ferriprox deferiprone 1000 mg film-coated tablet bottle
chiesi australia pty ltd - deferiprone, quantity: 1000 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; hypromellose; hyprolose; macrogol 8000; titanium dioxide; methylcellulose - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine or in whom desferrioxamine therapy has proven ineffective.
ferriprox deferiprone 50g/500ml oral solution bottle
chiesi australia pty ltd - deferiprone, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: glycerol; hydrochloric acid; sucralose; sunset yellow fcf; peppermint oil; hyetellose; purified water; flavour - indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; or in whom desferrioxamine therapy has proven ineffective.
ferriprox deferiprone 25g/250ml oral solution bottle
chiesi australia pty ltd - deferiprone, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sucralose; purified water; glycerol; sunset yellow fcf; hydrochloric acid; hyetellose; peppermint oil; flavour - indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; or in whom desferrioxamine therapy has proven ineffective.
ferriprox deferiprone 500mg tablets bottle
chiesi australia pty ltd - deferiprone, quantity: 500 mg - tablet, film coated - excipient ingredients: titanium dioxide; macrogol 3350; hypromellose; microcrystalline cellulose; silicon dioxide; magnesium stearate - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; or in whom desferrioxamine therapy has proven ineffective.
desferal
novartis pharmaceuticals uk limited - deferoxamine 500 mg - powder for solution for injection
prochlorperazine injection bp 12.5mg/ml.
mercury pharmaceuticals (ireland) ltd - prochlorperazine mesilate - solution for injection - 12.5 mg/ml
prochlorperazine injection bp 25mg in 2ml
mercury pharmaceuticals (ireland) ltd - prochlorperazine mesilate - solution for injection - 25 mg/ml